Evidence Archives

Molecular Subtyping Predicts Pathologic Tumor Response in Early-Stage Breast Cancer Treated with Neoadjuvant Docetaxel Plus Capecitabine with or without Trastuzumab Chemotherapy
Gallery
Molecular Subtyping Predicts Pathologic Tumor Response in Early-Stage Breast Cancer Treated with Neoadjuvant Docetaxel Plus Capecitabine with or without Trastuzumab Chemotherapy

BluePrint, Evidence, Neoadjuvant

Molecular Subtyping Predicts Pathologic Tumor Response in Early-Stage Breast Cancer Treated with Neoadjuvant Docetaxel Plus Capecitabine with or without Trastuzumab Chemotherapy

PUBLICATION: Med Oncol. (2014) 31: 163. https://doi.org/10.1007/s12032-014-0163-9. AUTHORS: Soley Bayraktar, Read More

kevin2024-03-25T10:18:35-07:00September 4th, 2014|BluePrint, Evidence, Neoadjuvant|

The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer
Gallery
The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

Adjuvant, Evidence, MammaPrint

The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

PUBLICATION: British Journal of Cancer, volume 111, pages 837–842 (26 Read More

kevin2024-03-25T10:20:39-07:00August 26th, 2014|Adjuvant, Evidence, MammaPrint|

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
Gallery
Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

Evidence, NBRST, Neoadjuvant

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)

PUBLICATION: Annals of Surgical Oncology; October 2014, Volume 21, Issue Read More

kevin2024-02-20T10:41:05-08:00August 7th, 2014|Evidence, NBRST, Neoadjuvant|

European Inter-Institutional Impact Study of MammaPrint
Gallery
European Inter-Institutional Impact Study of MammaPrint

Adjuvant, Evidence, MammaPrint

European Inter-Institutional Impact Study of MammaPrint

PUBLICATION: The Breast August 2014, Volume 23, Issue 4, Pages Read More

kevin2024-03-25T10:07:03-07:00August 1st, 2014|Adjuvant, Evidence, MammaPrint|

Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms
Gallery
Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

Adjuvant, Evidence, MammaPrint, RASTER

Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

PUBLICATION: Breast Cancer Res Treat. 2014 Jun;145(3):697-705. doi: 10.1007/s10549-014-2954-2. Epub Read More

kevin2024-03-25T10:21:40-07:00June 1st, 2014|Adjuvant, Evidence, MammaPrint, RASTER|

Risk Estimations and Treatment Decisions in Early Stage Breast Cancer: Agreement Among Oncologists and the Impact of the 70-Gene Signature
Gallery
Risk Estimations and Treatment Decisions in Early Stage Breast Cancer: Agreement Among Oncologists and the Impact of the 70-Gene Signature

Adjuvant, Evidence, MammaPrint, RASTER

Risk Estimations and Treatment Decisions in Early Stage Breast Cancer: Agreement Among Oncologists and the Impact of the 70-Gene Signature

PUBLICATION: Eur J Cancer. 2014 Apr;50(6):1045-54. doi: 10.1016/j.ejca.2014.01.016. Epub 2014 Read More

kevin2024-03-25T10:23:07-07:00April 1st, 2014|Adjuvant, Evidence, MammaPrint, RASTER|

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue
Gallery
MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

Evidence, MammaPrint, Other, Validation

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

PUBLICATION: J Mol Diagn. 2014 Mar;16(2):190-7. doi: 10.1016/j.jmoldx.2013.10.008. Epub 2013 Read More

kevin2024-03-25T10:23:52-07:00March 1st, 2014|Evidence, MammaPrint, Other, Validation|

Mammographic Screening Detects Low-Risk Tumor Biology Breast Cancers
Gallery
Mammographic Screening Detects Low-Risk Tumor Biology Breast Cancers

Adjuvant, Evidence, MammaPrint, MINDACT, Other

Mammographic Screening Detects Low-Risk Tumor Biology Breast Cancers

PUBLICATION: Breast Cancer Res Treat. 2014 Feb;144(1):103-11. doi: 10.1007/s10549-013-2830-5. Epub Read More

kevin2024-03-25T10:25:05-07:00February 2nd, 2014|Adjuvant, Evidence, MammaPrint, MINDACT, Other|

Long-Term Impact of the 70-Gene Signature on Breast Cancer Outcome
Gallery
Long-Term Impact of the 70-Gene Signature on Breast Cancer Outcome

Adjuvant, Evidence, MammaPrint, Other, Validation

Long-Term Impact of the 70-Gene Signature on Breast Cancer Outcome

PUBLICATION: Breast Cancer Res Treat. 2014 Feb;143(3):587-92. doi: 10.1007/s10549-013-2831-4. Epub Read More

kevin2024-03-25T10:40:13-07:00February 1st, 2014|Adjuvant, Evidence, MammaPrint, Other, Validation|

Prospective Cost-Effectiveness Analysis of Genomic Profiling in Breast Cancer
Gallery
Prospective Cost-Effectiveness Analysis of Genomic Profiling in Breast Cancer

Evidence, Healthcare Economics, MammaPrint, Other

Prospective Cost-Effectiveness Analysis of Genomic Profiling in Breast Cancer

PUBLICATION: European Journal of Cancer. December 2013, Volume 49, Issue Read More

kevin2024-03-25T11:21:23-07:00December 1st, 2013|Evidence, Healthcare Economics, MammaPrint, Other|